- Home
- AXSM vs GTLS Comparison
AXSM vs GTLS Comparison
Compare AXSM & GTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | GTLS |
|---|---|---|
| Founded | 2012 | 1859 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 9.3B |
| IPO Year | 2015 | 1992 |
Fundamental Metrics
Financial Performance| Metric | AXSM | GTLS |
|---|---|---|
| Price | $167.21 | $206.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 20 | 12 |
| Target Price | $183.10 | ★ $205.40 |
| AVG Volume (30 Days) | ★ 690.1K | 576.3K |
| Earning Date | 02-17-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.86 |
| Revenue | $561,263,000.00 | ★ $4,291,200,000.00 |
| Revenue This Year | $66.40 | $8.89 |
| Revenue Next Year | $56.13 | $10.26 |
| P/E Ratio | ★ N/A | $239.53 |
| Revenue Growth | ★ 65.83 | 5.47 |
| 52 Week Low | $79.19 | $104.60 |
| 52 Week High | $184.40 | $220.03 |
Technical Indicators
Market Signals| Indicator | AXSM | GTLS |
|---|---|---|
| Relative Strength Index (RSI) | 59.91 | 78.91 |
| Support Level | $168.58 | $205.95 |
| Resistance Level | $184.40 | $206.65 |
| Average True Range (ATR) | 6.66 | 0.46 |
| MACD | 1.25 | -0.07 |
| Stochastic Oscillator | 54.99 | 98.04 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About GTLS Chart Industries Inc.
Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas industries. It also provides natural gas processing solutions for the natural gas industry and specialty products that serve a variety of spaces, including hydrogen, biofuels, cannabis, and water treatment. The firm acquired Howden in a significant deal in early 2023, roughly doubling the size of the company. It plans to merge with Flowserve by the end of 2025.